/ /


Light-listening device could transform skin disease detectionThe future of skin cancer and other disease detection could change with the development of a photonics device that listens to light.
New treatment for kidney cancer gets OKFDA has approved lenvatinib (Lenvima, Eisai Inc.) in combination with everolimus for the treatment of advanced renal cell carcinoma.
Opdivo snags two new cancer approvalsNivolumab (Opdivo, Bristol-Myers Squibb) received two new approvals from FDA to treat two different cancers.
Smart skin that acts like the real thingResearchers have developed a recyclable paper-based smart skin, capable of detecting temperature, humidity, pH, pressure, touch, flow, motion and proximity at 13 cm.
New cosmeceutical contains multi-potent growth factorSuneva Medical’s new bovine-free serum is composed of more than 120 growth factors. In studies, users reported significant improvements in skin hydration, radiance, firmness and fine lines. Read more on the science.
App tracks mole images to compare over time
App tracks mole images to compare over timeDermatologist-developed technology complements other preventive and skin cancer monitoring approaches, may lead to earlier detection and fewer unnecessary biopsies.
New compounds may block melanoma tumor growthEarly study results indicate the potential for a new class of inhibitory compounds to enhance the effect of anti-tumor drugs in melanoma treatment. What the future may hold.
FDA approves ixekizumab for plaque psoriasisThe FDA approved Taltz (ixekizumab, Eli Lilly and Company) injection 80 mg/mL March 22 for treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy. Learn more


View Results